Global Tulathromycin Market Growth (Status and Outlook) 2025-2031

December 2025 | 83 pages | ID: G45761A58353EN
LP Information

Abstracts

According to this study, the global Tulathromycin market size will reach US$ million by 2031.

Tulathromycin is a macrolide antibiotic used to treat bovine respiratory disease (BRD) in cattle and swine respiratory disease in pigs.

United States market for Tulathromycin is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Tulathromycin is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Tulathromycin is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Tulathromycin players cover Zhejiang Genebest Pharmaceutical, AVF Chemical Industrial, Rochem, Livzon Group Fuzhou Fuxing Pharmaceutical Co.,Ltd, Hubei Honch Pharmaceutical Co.,ltd, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Tulathromycin Industry Forecast” looks at past sales and reviews total world Tulathromycin sales in 2024, providing a comprehensive analysis by region and market sector of projected Tulathromycin sales for 2025 through 2031. With Tulathromycin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tulathromycin industry.

This Insight Report provides a comprehensive analysis of the global Tulathromycin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Tulathromycin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Tulathromycin market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tulathromycin and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tulathromycin.

This report presents a comprehensive overview, market shares, and growth opportunities of Tulathromycin market by product type, application, key players and key regions and countries.

Segmentation by Type:

• >99%
• 98%-99%

Segmentation by Application:

• Pig
• Cattle

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Zhejiang Genebest Pharmaceutical
• AVF Chemical Industrial
• Rochem
• Livzon Group Fuzhou Fuxing Pharmaceutical Co.,Ltd
• Hubei Honch Pharmaceutical Co.,ltd
• Hubei Weideli Chemical Science and Technology Co., Ltd
• Zoetis
• Wuhan Kemick Biomedical Technology Co., Ltd

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Tulathromycin Market Size (2020-2031)
  2.1.2 Tulathromycin Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Tulathromycin by Country/Region (2020, 2024 & 2031)
2.2 Tulathromycin Segment by Type
  2.2.1 >99%
  2.2.2 98%-99%
2.3 Tulathromycin Market Size by Type
  2.3.1 Tulathromycin Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Tulathromycin Market Size Market Share by Type (2020-2025)
2.4 Tulathromycin Segment by Application
  2.4.1 Pig
  2.4.2 Cattle
2.5 Tulathromycin Market Size by Application
  2.5.1 Tulathromycin Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Tulathromycin Market Size Market Share by Application (2020-2025)

3 TULATHROMYCIN MARKET SIZE BY PLAYER

3.1 Tulathromycin Market Size Market Share by Player
  3.1.1 Global Tulathromycin Revenue by Player (2020-2025)
  3.1.2 Global Tulathromycin Revenue Market Share by Player (2020-2025)
3.2 Global Tulathromycin Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 TULATHROMYCIN BY REGION

4.1 Tulathromycin Market Size by Region (2020-2025)
4.2 Global Tulathromycin Annual Revenue by Country/Region (2020-2025)
4.3 Americas Tulathromycin Market Size Growth (2020-2025)
4.4 APAC Tulathromycin Market Size Growth (2020-2025)
4.5 Europe Tulathromycin Market Size Growth (2020-2025)
4.6 Middle East & Africa Tulathromycin Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Tulathromycin Market Size by Country (2020-2025)
5.2 Americas Tulathromycin Market Size by Type (2020-2025)
5.3 Americas Tulathromycin Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Tulathromycin Market Size by Region (2020-2025)
6.2 APAC Tulathromycin Market Size by Type (2020-2025)
6.3 APAC Tulathromycin Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Tulathromycin Market Size by Country (2020-2025)
7.2 Europe Tulathromycin Market Size by Type (2020-2025)
7.3 Europe Tulathromycin Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Tulathromycin by Region (2020-2025)
8.2 Middle East & Africa Tulathromycin Market Size by Type (2020-2025)
8.3 Middle East & Africa Tulathromycin Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL TULATHROMYCIN MARKET FORECAST

10.1 Global Tulathromycin Forecast by Region (2026-2031)
  10.1.1 Global Tulathromycin Forecast by Region (2026-2031)
  10.1.2 Americas Tulathromycin Forecast
  10.1.3 APAC Tulathromycin Forecast
  10.1.4 Europe Tulathromycin Forecast
  10.1.5 Middle East & Africa Tulathromycin Forecast
10.2 Americas Tulathromycin Forecast by Country (2026-2031)
  10.2.1 United States Market Tulathromycin Forecast
  10.2.2 Canada Market Tulathromycin Forecast
  10.2.3 Mexico Market Tulathromycin Forecast
  10.2.4 Brazil Market Tulathromycin Forecast
10.3 APAC Tulathromycin Forecast by Region (2026-2031)
  10.3.1 China Tulathromycin Market Forecast
  10.3.2 Japan Market Tulathromycin Forecast
  10.3.3 Korea Market Tulathromycin Forecast
  10.3.4 Southeast Asia Market Tulathromycin Forecast
  10.3.5 India Market Tulathromycin Forecast
  10.3.6 Australia Market Tulathromycin Forecast
10.4 Europe Tulathromycin Forecast by Country (2026-2031)
  10.4.1 Germany Market Tulathromycin Forecast
  10.4.2 France Market Tulathromycin Forecast
  10.4.3 UK Market Tulathromycin Forecast
  10.4.4 Italy Market Tulathromycin Forecast
  10.4.5 Russia Market Tulathromycin Forecast
10.5 Middle East & Africa Tulathromycin Forecast by Region (2026-2031)
  10.5.1 Egypt Market Tulathromycin Forecast
  10.5.2 South Africa Market Tulathromycin Forecast
  10.5.3 Israel Market Tulathromycin Forecast
  10.5.4 Turkey Market Tulathromycin Forecast
10.6 Global Tulathromycin Forecast by Type (2026-2031)
10.7 Global Tulathromycin Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Tulathromycin Forecast

11 KEY PLAYERS ANALYSIS

11.1 Zhejiang Genebest Pharmaceutical
  11.1.1 Zhejiang Genebest Pharmaceutical Company Information
  11.1.2 Zhejiang Genebest Pharmaceutical Tulathromycin Product Offered
  11.1.3 Zhejiang Genebest Pharmaceutical Tulathromycin Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Zhejiang Genebest Pharmaceutical Main Business Overview
  11.1.5 Zhejiang Genebest Pharmaceutical Latest Developments
11.2 AVF Chemical Industrial
  11.2.1 AVF Chemical Industrial Company Information
  11.2.2 AVF Chemical Industrial Tulathromycin Product Offered
  11.2.3 AVF Chemical Industrial Tulathromycin Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 AVF Chemical Industrial Main Business Overview
  11.2.5 AVF Chemical Industrial Latest Developments
11.3 Rochem
  11.3.1 Rochem Company Information
  11.3.2 Rochem Tulathromycin Product Offered
  11.3.3 Rochem Tulathromycin Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Rochem Main Business Overview
  11.3.5 Rochem Latest Developments
11.4 Livzon Group Fuzhou Fuxing Pharmaceutical Co.,Ltd
  11.4.1 Livzon Group Fuzhou Fuxing Pharmaceutical Co.,Ltd Company Information
  11.4.2 Livzon Group Fuzhou Fuxing Pharmaceutical Co.,Ltd Tulathromycin Product Offered
  11.4.3 Livzon Group Fuzhou Fuxing Pharmaceutical Co.,Ltd Tulathromycin Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Livzon Group Fuzhou Fuxing Pharmaceutical Co.,Ltd Main Business Overview
  11.4.5 Livzon Group Fuzhou Fuxing Pharmaceutical Co.,Ltd Latest Developments
11.5 Hubei Honch Pharmaceutical Co.,ltd
  11.5.1 Hubei Honch Pharmaceutical Co.,ltd Company Information
  11.5.2 Hubei Honch Pharmaceutical Co.,ltd Tulathromycin Product Offered
  11.5.3 Hubei Honch Pharmaceutical Co.,ltd Tulathromycin Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Hubei Honch Pharmaceutical Co.,ltd Main Business Overview
  11.5.5 Hubei Honch Pharmaceutical Co.,ltd Latest Developments
11.6 Hubei Weideli Chemical Science and Technology Co., Ltd
  11.6.1 Hubei Weideli Chemical Science and Technology Co., Ltd Company Information
  11.6.2 Hubei Weideli Chemical Science and Technology Co., Ltd Tulathromycin Product Offered
  11.6.3 Hubei Weideli Chemical Science and Technology Co., Ltd Tulathromycin Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Hubei Weideli Chemical Science and Technology Co., Ltd Main Business Overview
  11.6.5 Hubei Weideli Chemical Science and Technology Co., Ltd Latest Developments
11.7 Zoetis
  11.7.1 Zoetis Company Information
  11.7.2 Zoetis Tulathromycin Product Offered
  11.7.3 Zoetis Tulathromycin Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Zoetis Main Business Overview
  11.7.5 Zoetis Latest Developments
11.8 Wuhan Kemick Biomedical Technology Co., Ltd
  11.8.1 Wuhan Kemick Biomedical Technology Co., Ltd Company Information
  11.8.2 Wuhan Kemick Biomedical Technology Co., Ltd Tulathromycin Product Offered
  11.8.3 Wuhan Kemick Biomedical Technology Co., Ltd Tulathromycin Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Wuhan Kemick Biomedical Technology Co., Ltd Main Business Overview
  11.8.5 Wuhan Kemick Biomedical Technology Co., Ltd Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Tulathromycin Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Tulathromycin Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of >99%
Table 4. Major Players of 98%-99%
Table 5. Tulathromycin Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Tulathromycin Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Tulathromycin Market Size Market Share by Type (2020-2025)
Table 8. Tulathromycin Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Tulathromycin Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Tulathromycin Market Size Market Share by Application (2020-2025)
Table 11. Global Tulathromycin Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Tulathromycin Revenue Market Share by Player (2020-2025)
Table 13. Tulathromycin Key Players Head office and Products Offered
Table 14. Tulathromycin Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Tulathromycin Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Tulathromycin Market Size Market Share by Region (2020-2025)
Table 19. Global Tulathromycin Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Tulathromycin Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Tulathromycin Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Tulathromycin Market Size Market Share by Country (2020-2025)
Table 23. Americas Tulathromycin Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Tulathromycin Market Size Market Share by Type (2020-2025)
Table 25. Americas Tulathromycin Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Tulathromycin Market Size Market Share by Application (2020-2025)
Table 27. APAC Tulathromycin Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Tulathromycin Market Size Market Share by Region (2020-2025)
Table 29. APAC Tulathromycin Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Tulathromycin Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Tulathromycin Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Tulathromycin Market Size Market Share by Country (2020-2025)
Table 33. Europe Tulathromycin Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Tulathromycin Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Tulathromycin Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Tulathromycin Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Tulathromycin Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Tulathromycin
Table 39. Key Market Challenges & Risks of Tulathromycin
Table 40. Key Industry Trends of Tulathromycin
Table 41. Global Tulathromycin Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Tulathromycin Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Tulathromycin Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Tulathromycin Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. Zhejiang Genebest Pharmaceutical Details, Company Type, Tulathromycin Area Served and Its Competitors
Table 46. Zhejiang Genebest Pharmaceutical Tulathromycin Product Offered
Table 47. Zhejiang Genebest Pharmaceutical Tulathromycin Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Zhejiang Genebest Pharmaceutical Main Business
Table 49. Zhejiang Genebest Pharmaceutical Latest Developments
Table 50. AVF Chemical Industrial Details, Company Type, Tulathromycin Area Served and Its Competitors
Table 51. AVF Chemical Industrial Tulathromycin Product Offered
Table 52. AVF Chemical Industrial Tulathromycin Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. AVF Chemical Industrial Main Business
Table 54. AVF Chemical Industrial Latest Developments
Table 55. Rochem Details, Company Type, Tulathromycin Area Served and Its Competitors
Table 56. Rochem Tulathromycin Product Offered
Table 57. Rochem Tulathromycin Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Rochem Main Business
Table 59. Rochem Latest Developments
Table 60. Livzon Group Fuzhou Fuxing Pharmaceutical Co.,Ltd Details, Company Type, Tulathromycin Area Served and Its Competitors
Table 61. Livzon Group Fuzhou Fuxing Pharmaceutical Co.,Ltd Tulathromycin Product Offered
Table 62. Livzon Group Fuzhou Fuxing Pharmaceutical Co.,Ltd Tulathromycin Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Livzon Group Fuzhou Fuxing Pharmaceutical Co.,Ltd Main Business
Table 64. Livzon Group Fuzhou Fuxing Pharmaceutical Co.,Ltd Latest Developments
Table 65. Hubei Honch Pharmaceutical Co.,ltd Details, Company Type, Tulathromycin Area Served and Its Competitors
Table 66. Hubei Honch Pharmaceutical Co.,ltd Tulathromycin Product Offered
Table 67. Hubei Honch Pharmaceutical Co.,ltd Tulathromycin Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Hubei Honch Pharmaceutical Co.,ltd Main Business
Table 69. Hubei Honch Pharmaceutical Co.,ltd Latest Developments
Table 70. Hubei Weideli Chemical Science and Technology Co., Ltd Details, Company Type, Tulathromycin Area Served and Its Competitors
Table 71. Hubei Weideli Chemical Science and Technology Co., Ltd Tulathromycin Product Offered
Table 72. Hubei Weideli Chemical Science and Technology Co., Ltd Tulathromycin Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. Hubei Weideli Chemical Science and Technology Co., Ltd Main Business
Table 74. Hubei Weideli Chemical Science and Technology Co., Ltd Latest Developments
Table 75. Zoetis Details, Company Type, Tulathromycin Area Served and Its Competitors
Table 76. Zoetis Tulathromycin Product Offered
Table 77. Zoetis Tulathromycin Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Zoetis Main Business
Table 79. Zoetis Latest Developments
Table 80. Wuhan Kemick Biomedical Technology Co., Ltd Details, Company Type, Tulathromycin Area Served and Its Competitors
Table 81. Wuhan Kemick Biomedical Technology Co., Ltd Tulathromycin Product Offered
Table 82. Wuhan Kemick Biomedical Technology Co., Ltd Tulathromycin Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. Wuhan Kemick Biomedical Technology Co., Ltd Main Business
Table 84. Wuhan Kemick Biomedical Technology Co., Ltd Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Tulathromycin Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Tulathromycin Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Tulathromycin Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Tulathromycin Sales Market Share by Country/Region (2024)
Figure 8. Tulathromycin Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Tulathromycin Market Size Market Share by Type in 2024
Figure 10. Tulathromycin in Pig
Figure 11. Global Tulathromycin Market: Pig (2020-2025) & ($ millions)
Figure 12. Tulathromycin in Cattle
Figure 13. Global Tulathromycin Market: Cattle (2020-2025) & ($ millions)
Figure 14. Global Tulathromycin Market Size Market Share by Application in 2024
Figure 15. Global Tulathromycin Revenue Market Share by Player in 2024
Figure 16. Global Tulathromycin Market Size Market Share by Region (2020-2025)
Figure 17. Americas Tulathromycin Market Size 2020-2025 ($ millions)
Figure 18. APAC Tulathromycin Market Size 2020-2025 ($ millions)
Figure 19. Europe Tulathromycin Market Size 2020-2025 ($ millions)
Figure 20. Middle East & Africa Tulathromycin Market Size 2020-2025 ($ millions)
Figure 21. Americas Tulathromycin Value Market Share by Country in 2024
Figure 22. United States Tulathromycin Market Size Growth 2020-2025 ($ millions)
Figure 23. Canada Tulathromycin Market Size Growth 2020-2025 ($ millions)
Figure 24. Mexico Tulathromycin Market Size Growth 2020-2025 ($ millions)
Figure 25. Brazil Tulathromycin Market Size Growth 2020-2025 ($ millions)
Figure 26. APAC Tulathromycin Market Size Market Share by Region in 2024
Figure 27. APAC Tulathromycin Market Size Market Share by Type (2020-2025)
Figure 28. APAC Tulathromycin Market Size Market Share by Application (2020-2025)
Figure 29. China Tulathromycin Market Size Growth 2020-2025 ($ millions)
Figure 30. Japan Tulathromycin Market Size Growth 2020-2025 ($ millions)
Figure 31. South Korea Tulathromycin Market Size Growth 2020-2025 ($ millions)
Figure 32. Southeast Asia Tulathromycin Market Size Growth 2020-2025 ($ millions)
Figure 33. India Tulathromycin Market Size Growth 2020-2025 ($ millions)
Figure 34. Australia Tulathromycin Market Size Growth 2020-2025 ($ millions)
Figure 35. Europe Tulathromycin Market Size Market Share by Country in 2024
Figure 36. Europe Tulathromycin Market Size Market Share by Type (2020-2025)
Figure 37. Europe Tulathromycin Market Size Market Share by Application (2020-2025)
Figure 38. Germany Tulathromycin Market Size Growth 2020-2025 ($ millions)
Figure 39. France Tulathromycin Market Size Growth 2020-2025 ($ millions)
Figure 40. UK Tulathromycin Market Size Growth 2020-2025 ($ millions)
Figure 41. Italy Tulathromycin Market Size Growth 2020-2025 ($ millions)
Figure 42. Russia Tulathromycin Market Size Growth 2020-2025 ($ millions)
Figure 43. Middle East & Africa Tulathromycin Market Size Market Share by Region (2020-2025)
Figure 44. Middle East & Africa Tulathromycin Market Size Market Share by Type (2020-2025)
Figure 45. Middle East & Africa Tulathromycin Market Size Market Share by Application (2020-2025)
Figure 46. Egypt Tulathromycin Market Size Growth 2020-2025 ($ millions)
Figure 47. South Africa Tulathromycin Market Size Growth 2020-2025 ($ millions)
Figure 48. Israel Tulathromycin Market Size Growth 2020-2025 ($ millions)
Figure 49. Turkey Tulathromycin Market Size Growth 2020-2025 ($ millions)
Figure 50. GCC Countries Tulathromycin Market Size Growth 2020-2025 ($ millions)
Figure 51. Americas Tulathromycin Market Size 2026-2031 ($ millions)
Figure 52. APAC Tulathromycin Market Size 2026-2031 ($ millions)
Figure 53. Europe Tulathromycin Market Size 2026-2031 ($ millions)
Figure 54. Middle East & Africa Tulathromycin Market Size 2026-2031 ($ millions)
Figure 55. United States Tulathromycin Market Size 2026-2031 ($ millions)
Figure 56. Canada Tulathromycin Market Size 2026-2031 ($ millions)
Figure 57. Mexico Tulathromycin Market Size 2026-2031 ($ millions)
Figure 58. Brazil Tulathromycin Market Size 2026-2031 ($ millions)
Figure 59. China Tulathromycin Market Size 2026-2031 ($ millions)
Figure 60. Japan Tulathromycin Market Size 2026-2031 ($ millions)
Figure 61. Korea Tulathromycin Market Size 2026-2031 ($ millions)
Figure 62. Southeast Asia Tulathromycin Market Size 2026-2031 ($ millions)
Figure 63. India Tulathromycin Market Size 2026-2031 ($ millions)
Figure 64. Australia Tulathromycin Market Size 2026-2031 ($ millions)
Figure 65. Germany Tulathromycin Market Size 2026-2031 ($ millions)
Figure 66. France Tulathromycin Market Size 2026-2031 ($ millions)
Figure 67. UK Tulathromycin Market Size 2026-2031 ($ millions)
Figure 68. Italy Tulathromycin Market Size 2026-2031 ($ millions)
Figure 69. Russia Tulathromycin Market Size 2026-2031 ($ millions)
Figure 70. Egypt Tulathromycin Market Size 2026-2031 ($ millions)
Figure 71. South Africa Tulathromycin Market Size 2026-2031 ($ millions)
Figure 72. Israel Tulathromycin Market Size 2026-2031 ($ millions)
Figure 73. Turkey Tulathromycin Market Size 2026-2031 ($ millions)
Figure 74. Global Tulathromycin Market Size Market Share Forecast by Type (2026-2031)
Figure 75. Global Tulathromycin Market Size Market Share Forecast by Application (2026-2031)
Figure 76. GCC Countries Tulathromycin Market Size 2026-2031 ($ millions)